Solution structure of the tetrameric minimum transforming domain of p53

Nature Structural Biology

Volumn 1, Issue 12, 1994, Pages 877-890

  Lee, Weontae ^a   Harvey, Timothy S ^a,c   Yin, Ya ^a   Yau, Patrick ^a   Litchfield, David ^b   Arrowsmith, Cheryl H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84970061891     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb1294-877     Document Type: Article

References (84)

1. Levine, A.J., Momand, C.A, & Finlay, C.A. The p53 tumour suppressor gene. Nature 351, 453-456 (1991).
2. Hollstein, M., Sldransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancer. Science 253, 49-53 (1991).
3. Donehower, L.A. & Bradley, A. The tumor suppressor p53. Biochimi. biophys. Acta 1155, 181-205 (1993).
4. Zambetti, G.P. & Levine, A.J. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7, 855-865 (1993).
5. Mercer, W.E., Amin, M., Sauve, G.J., Appella, E., Ullrich, S.J. & Romano, J. Wild-type human p53 is antiproliferative in SV40- transformed hamster cells. Oncogene 5, 973-980 (1990).
6. Mercer, W.E., Shields, M.T., Amin, M., Sauve, G.J., Appella, E. & Ullrich, S.J. Negative growth regulation In a glioblastoma cell line that conditionally expresses human wild-type p53. Proc. natn. Acad. Sci. U.S.A. 87, 6166-6170(1990).
7. Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K.V. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.
8. Chen, P.-L., Chen, Y., Bookstein, R. & Lee, W.-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science 250, 1576-1580(1990).
9. Diller, L. et al. p53 functions as a cell cycle control protein In osteosarcomas. Molec. Cell. Biol. 10, 5772-5781 (1990).
10. Lin, D., Shields, M., Ullrich, S., Appella E. & Mercer, W. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G, phase. Proc. natn. Acad. Sci. U.S.A. 89, 9210-9214(1992).
11. Martinez, J., Georgoff, I. Martinez, J. & Levine, A.J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Develop. 5, 151-159 (1991).
12. Shaulsky, G., Goldflnger, N., & Rotter, V. Alterations In tumor development in vivo mediated by expression of wild type and mutant p53 proteins. Cancer Res. 51, 5232-5237 (1991).
13. Wolf, D., Admon, S., Oren, M., & Rotter, V. Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species. Molec Cell. Biol. 4, 552-558 (1984).
14. Kastan, M.B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
15. El-Delry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
16. Harper, J.W., Adam, G.R., Wei, N, Keyomarsl, K. & Elledge, S.J. Thep21 cdk-lnteracting protein CIp 1 Is a potent Inhibitor of G1 cyclln-dependent kinases. Cell 75, 805-816 (1993).
17. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashl, R. & Beach, D. p21 Is a universal Inhibitor of cyclln kinases. Nature 366, 701-704(1993).
18. Gu, Y, Turck, C.W. & Morgan, D.O. Inhibition of CDK2 activity In vivo by an associated 20K regulatory subunit. Nature 366, 707-710 (1993).
19. Lane, D.P. P53, Guardian of the genome. Nature 358, 15-16 (1992).
20. Milner, J. & Medcalf, E.A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65, 765-774(1991).
21. Bargonetti, J., Reynisdottir, J, Friedman, P.N. & Prives, C. Site specific binding of wild-type p53 to cellular DNA Is Inhibited by SV40 T antigen and mutant p53. Genes Develop. 6, 1886-1898 (1992).
22. Shaulian, E., Zauberman, A., Ginsberg, D. & Oren, M. Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA-blndlng. Molec Cell. Biol. 12, 5581-5592 (1992).
23. Friedman, P.N., Chen, X., Bargonetti, J. & Prives, C. The p53 protein Is an unusually shaped tetramer that binds directly to DNA. Proc. natn. Acad. Sci. U.S.A. 90, 3319-3323 (1993).
24. Hainaut, P. & Milner, J. Redox modulation of p53 conformation and sequence specific DNA-blnding in vitro. Cancer Res. 53, 4469-4473 (1993).
25. Cho, Y., Gorina, S., Jeffrey, P. & Pavletich, N. Crystal structure of p53 tumor suppressor-DNA complex: understanding tumorlgenic mutations. Science 265, 346-355 (1994).
26. Pavletich, N., Chambers, K.A. & Pabo, C.A. The DNA-blnding doman of p53 contains the four conserved regions and the major mutation hot spots. Genes Develop. 7, 2556-2564 (1993).
27. Halazonetls, T.D. & Kandll, A.N. Conformational shifts propagate from the oligomerization domain of p53 to Its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12, 5057-5064(1993).
28. Wang, Y. etal. p53 domains: Identification and characterization of two autonomous DNA-blndlng regions. Genes Develop. 7, 2575-258(1993).
29. Stürzbecher H.W. et ai A C-terminal a-hellx plus basic region motif Is the major structural determinant of p53 tetramerization. Oncogene 7, 1513-1523 (1992).
30. Wang, P. et al. p53 domains: structure, oligomerization, and transformation. Molec. Cell. Biol. 14, 5182-5191 (1994).
31. Sakamoto, H., Lewis, M.S., Kodama, H., Appella, E., and Sakaguchi, K. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers In solution. Proc. natn. Acad. Sci. U.S.A. 91, 8974-8978 (1994).
32. Sturzbecher, H.W. etal. p53 Interacts with p34 2 In mammalian cells: Implications for cell cycle control and oncogenesis. Oncogene 5, 595-801 (1990).
33. Hupp, T.R., Meek, D.W., Midgley, C.A & Lane, D.P. Regulation of the specific DNA binding function of p53. Cell 71, 875-886 (1992).
34. El-Delry, W.S., Kern, S.E., Pletenpol, J.A., Klzler, K.W. & Vogelstein, B., Definition of a consensus binding site for p53. Nature Genet. 1, 45-49(1992).
35. Bodenhausen, G. & Ruben, D. J. Natural abundance nitrogen-15 NMR by enhanced heteronuclearspectroscopy. Chem. Phys. Lett. 69, 185-189(1980).
36. Bax, A. & Davis, D.G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. magn. Reson. 65, 355 (1985).
37. Folkers, PJ.M, Folmer, R.H.A, Konlgs, R.N.H, & Hllbers, C.W. Overcoming the ambiguity problem encountered In the analysis of nuclear Overhauser magnetic resonance spectra of symmetric dimer proteins. J. Am. chem. Soc. 115, 3798-3799 (1993).
38. Ikura, M; Clore, G.M.; Gronenborn, A.M.; Zhu, G.; Klee, C.B & Bax, A. Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 256, 632-638 (1992).
39. Lee, W., Revington, M.J., Arrowsmlth, C.H. & Kay, L.E. A pulsed field gradient isotope-filtered 3D, 3C HMQC-NOESY experiment for extracting intermolecular NOE contacts In molecular complexes. FEBS Letts. 350, 87-90(1994).
40. Brunger, A.T. X-PLOR version 3.1: A system for X-Ray crystallography and NMR (Yale University Press, New Haven; 1993).
41. Harris, N.L., Presnell, S.R., & Cohen, F.R. Four helix bundle diversity in globular proteins. J. molec. Biol. 236, 1356-1368 (1994).
42. Elsenberg, D. & McLachlan, A.D. Solvation energy In protein folding and binding. Nature, 319, 199-203 (1986).
43. Chlche, L., Gregoret, L.M., Cohen, F.E., & Kollman, P.A. Protein model structure evaluation using the solvation free energy of folding. Proc. natn. Acad. Sci. U.S.A. 87, 3240-3243 (1990).
44. Schultz, G.E. & Schlrmer, R.H. Principles of protein structure, (Sprlnger-Verlag, New York, 1979).
45. O'Shea, E.K., Klemm, J.D., Kim, PS. & Alber, T. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel colled-colI. Science 254, 539-543 (1991).
46. Clore, G.M. etal. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science 265, 386-391 (1994).
47. Foord, O.S., Bhattacharya, P. Reich, Z, & Rotter, V. The DNA-blndlng domain Is contained In the C-termlnusof wild-type p53 protein. Nucleic Acids Res. 19, 5191-5198 (1991).
48. Slngerland, J.M., Jenkins, J.R. & Benchlmol, S. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO. J 12, 1029-1037 (1993).
49. Kern, S., Klnszler, K., Bruskln, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. (1991). Identification of p53 as a sequence-specific DNA-blndlng protein. Science 252, 1708-1711.
50. Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E., & Shay, J.W. A transcriptionally active DNA-bindingsIte for human p53 protein complexes. Molec Cell. Biol. 12, 2866-2871 (1992).
51. Halazonetis, T.D., Davis, LJ. & Kandll, A.N. Wild-type p53 adopts a 'mutant-llke' conformation when bound to DNA. EMBOJ. 12, 1021-1028 (1993).
52. Milner, J. & Medcalf, E.A. Temperature-dependent swlthching between 'wild-type' and 'mutant' forms of p53-Val 135. J. molec. Biol. 216, 481-484(1990).
53. Ulrich, S.J., Mercer, W.E. & Appella, E. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells. Oncogene 7, 1635-1643 (1992).
54. Meek, D.W., Simon, S., Kikkawa, U. & Eckart, W. The p53 tumour suppressor protein Is phosphorylated at Serine 389 by casein kinase II. EMBO J. 9, 3253-3260 (1990).
55. Studler, F.W., Rosenberg, A.H., Dunn, J.J. & Dubendorff, J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Meths. Enzymol. 185, 60-89 (1990).
56. Sambrook, J., Frltsch, E.F. & Manlatls, T. Molecular Cloning, 2nd Ed. (Cold Spring Harbor Press, Cold Spring Harbor; 1989).
57. Chan, A.K., Litchfield, D.W. & Wright, J.A. Phosphorylation of ribonucleotide reductase R2 protein: in vivo and in vitro evidence of a role for p34cdc2 and CDK2 protein kinases. Biochemistry 32: 12835-12840 (1993).
58. Kay, L. E., Keifer, P. & Saarinen, T. Pure absorption gradient enhanced heteronudear single quantum correlation spectroscopy with improved sensitivity. J. Am. chem. Soc. 114, 10663-10668 (1992).
59. Kay, L. E., Ikura, M., Tschudin, R. & Bax, A. Three-dimensional triple-resonance NMR spectroscopy of isotoplcally enriched proteins. J. magn. Reson. 89. 496-514(1990).
60. 3D NMR experiment to correlate amide proton and nitrogen resonances with the alpha and beta carbon resonances in proteins. J. magn. Reson. 101 201-205 (1993).
61. Grzesiek, S. & Bax, A. Correlating backbone amide and sldechaln resonances in larger proteins by multiple relayed triple resonance NMR. J. Am. chem. Soc. 114, 6291-6293 (1992).
62. Kay, L.E. J. Am. chem. Soc. 115, 2055-2057 (1993).
63. McCoy, M. and Mueller, L. J. (1992). Selective shaped pulse decoupling In NMR: homonuclear [carbon-C13] carbonyl decoupling. J. Am. chem. Soc. 114, 2108-2112 (1992).
64. Shaka, A. J., Barker, P. B. & Freeman, R. J. Computer-optimized decoupling scheme for wideband applications and low level operation. J. magn. Reson. 64, 547 (1985).
65. Clore, G.M. & Gronenborn, A.M. Structures of larger proteins, proteln-lIgand and proteln-DNA complexes by multidimensional heteronudear NMR spectroscopy. Prot. Sci. 3, 372-390 (1994).
66. Bagby, S., Harvey, T.S., Kay, L.E., Eagle, S.G., Inouye, S., & Ikura, M. NMR-derived three-dimensional structure of protein S complexed with calcium. Structure 2, 107-122 (1994).
67. 3C-enrlched proteins. J. magn. Reson. 88, 425-431.
68. 15N Hartmann-Hahn-Multlple quantum coherence and Nuclear Overhauser-Multlple quantum coherence spectroscopy: Application to Interleukin 1b. Biochemistry 28, 6150-6156 (1989).
69. Shaka, A. J., Lee, F. D. & Pines, A. Iterative schemes for bilinear operators: application to spin decoupling. J. magn. Reson. 77, 274-293 (1988).
70. 5a. Biochemistry, 28, 2387-2391 (1989).
71. 15N-labelled proteins. J. Am. chem. Soc. 111, 1515-1517 (1989).
72. 20. J. magn. Reson. B103, 197-201 (1994).
73. 5N spectra of larger proteins: Heteronudear triple resonance 3D NMR spectroscopy. Biochemistry 29, 4659-4667 (1990).
74. Muhandiram, D. R., Farrow, N., Xu, G. Y., Smallcombe, S. J. & Kay, L. E. A gradient 13C NOESY-HSQC experiment for recording NOESY spectra of 13C labelled proteins dissolved In H20. J. magn. Reson. B102, 317-321 (1993).
75. Kay, L. E. & Bax, A. A new method for the measurement of NH- CaH coupling constants In 15N-labelled proteins. J. magn. Reson. 86, 110-126(1990).
76. Shaka, A. J., Keeler, J., Frenkiel, T. & Freeman, R. J. An Improved sequence for broadband decoupling: Waltz-16, J. magn. Reson. 52, 335-338(1983).
77. Delaglio, F. NMRPipe System of Software (National Institutes of Health, Bethesda: 1993).
78. Garrett, D. S., Powers, R., Gronenborn, A. M. & Clore, G.M. A common sense approach to peak picking In two-, three-, and fourdimensional spectra using automatic computer analysis of contour diagrams. J. magn. Reson. 95, 214-220 (1991).
79. 1H NMR. Proteins Struct. Funct. Genet. 17, 295-309 (1993).
80. Wuthrich, K., Bllleter, M. & Braun, W. Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of Intramolecular proton-proton distance constraints with nuclear magnetic resonance. J molec. Biol. 169, 949-961 (1983).
81. 1H NMR studies of human lysozyme: spectral assignment and comparison with hen lysozyme. Biochemistry 29, 7201-7214 (1990).
82. Wlshart, D.S., Sykes, B.D., & Richards, F.M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31, 1647-1651 (1992).
83. Kraulis, P.J. Molscript: a program to produce both detailed and schematic plots for protein structures. J. appl. Crystallogr. 24, 946-950 (1991).
84. Evans, S.V. SETOR: hardware-lighted three dimensional solid model representation of macromolecules (1993).